Rice bran arabinoxylan compound as a natural product for cancer treatment – an evidence-based assessment of the effects and mechanisms

References

• Alshaibi HF, Al-Shehri B, Hassan B, Al-Zahrani R, Assiss T. 2020. Modulated electrohyperthermia: a new hope for cancer patients. Biomed Res Int. 2020:8814878–8814813. doi: 10.1155/2020/8814878.
   PubMedGoogle Scholar
• Altun İ, Sonkaya A. 2018. The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran J Public Health. 47(8):1218–1219.
   PubMed Web of Science ®Google Scholar
• American Society of Clinical Oncology. 1996. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol. 14:671–679.
   PubMed Web of Science ®Google Scholar
• Amjad MT, Chidharla A, Kasi A. 2023. Cancer chemotherapy. Treasure Island. (FL): StatPearls Publishing; [accessed 2023 Nov 9]. https://www.ncbi.nlm.nih.gov/books/NBK564367/.
   Google Scholar
• An SY. 2011. Immune-enhance and anti-tumor effect of exo-biopolymer extract from submerged culture of Lentinus edodes with rice bran. [dissertation]. Seoul (Republic of Korea): Korea University.
   Google Scholar
• Andocs G, Szasz O, Szasz A. 2009. Oncothermia treatment of cancer: from the laboratory to clinic. Electromagn Biol Med. 28(2):148–165. doi: 10.1080/15368370902724633.
   PubMed Web of Science ®Google Scholar
• Ba Y, Shi Y, Jiang W, Feng J, Cheng Y, Xiao L, Zhang Q, Qiu W, Xu B, Xu R, et al. 2020. Current management of chemotherapy-induced neuxtropenia in adults: key points and new challenges: committee of neoplastic supportive-care (CONS). China anti-cancer Association Committee of Clinical Chemotherapy, China anti-cancer Association. Cancer Biol Med. 17:896–909.)
   PubMedGoogle Scholar
• Badr El-Din NK, Abdel Fattah SM, Pan D, Tolentino L, Ghoneum M. 2016a. Chemopreventive activity of MGN-3/Biobran against chemical induction of glandular stomach carcinogenesis in rats and its apoptotic effect in gastric cancer cells. Integr Cancer Ther. 15(4):NP26–NP34. doi: 10.1177/1534735416642287.
   PubMed Web of Science ®Google Scholar
• Badr El-Din NK, Ali DA, Alaa El-Dein M, Ghoneum M. 2016b. Enhancing the apoptotic effect of a low dose of paclitaxel on tumor cells in mice by arabinoxylan rice bran (MGN-3/Biobran). Nutr Cancer. 68(6):1010–1020. doi: 10.1080/01635581.2016.1192204.
   PubMed Web of Science ®Google Scholar
• Badr El-Din NK, Ali DA, Othman RM. 2016c. Inhibition of experimental carcinogenesis by the bioactive natural product Biobran. J Plant Prot Pathol. 7(1):85–91.
   Google Scholar
• Badr El-Din NK, Ali DA, Othman R, French SW, Ghoneum M. 2020. Chemopreventive role of arabinoxylan rice bran, MGN-3/Biobran, on liver carcinogenesis in rats. Biomed Pharmacother. 126:110064. doi: 10.1016/j.biopha.2020.110064.
   PubMed Web of Science ®Google Scholar
• Badr El-Din NK, Areida SK, Ahmed KO, Ghoneum M. 2019. Arabinoxylan rice bran (MGN-3/Biobran) enhances radiotherapy in animals bearing Ehrlich ascites carcinoma. J Radiat Res. 60(6):747–758. doi: 10.1093/jrr/rrz055.
   PubMed Web of Science ®Google Scholar
• Badr El-Din NK, Mahmoud AZ, Hassan TA, Ghoneum M. 2018. Baker’s yeast sensitizes metastatic breast cancer cells to paclitaxel in vitro. Integr Cancer Ther. 17(2):542–550. doi: 10.1177/1534735417740630.
   PubMed Web of Science ®Google Scholar
• Badr El-Din NK, Noaman E, Ghoneum M. 2008. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on Ehrlich carcinoma-bearing mice. Nutrit Cancer. 60(2):235–244. doi: 10.1080/01635580701627285.
   PubMed Web of Science ®Google Scholar
• Bae MJ, Lee ST, Sy C, Shin SH, Kwon SH, Park MH, Song MY, Hwang SJ. 2004. The effects of the arabinoxylane and the polysaccharide peptide (PSP) on the antiallergy, anticancer. J Korean Soc Food Sci Nutr. 33:469–474.
   Google Scholar
• Bang MH, Van Riep T, Thinh NT, Song LH, Dung TT, Van Truong L, Van Don L, Ky TD, Pan D, Shaheen M. 2010. Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial. Anticancer Res. 30:5145–5151.
   PubMed Web of Science ®Google Scholar
• Barnes JL, Zubair M, John K, Poirier MC, Martin FL. 2018. Carcinogens and DNA damage. Biochem Soc Trans. 46(5):1213–1224. doi: 10.1042/BST20180519.
   PubMedGoogle Scholar
• Baskar R, Lee KA, Yeo R, Yeoh K-W. 2012. Cancer and radiation therapy: current advances and future directions [Review]. Int J Med Sci. 9(3):193–199. doi: 10.7150/ijms.3635.
   PubMed Web of Science ®Google Scholar
• Blackadar CB. 2016. Historical review of the causes of cancer. WJCO. 7(1):54–86. doi: 10.5306/wjco.v7.i1.54.
   Google Scholar
• Bray F, Laversanne M, Weiderpass E, Soerjomataram I. 2021. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16):3029–3030. doi: 10.1002/cncr.33587.
   PubMed Web of Science ®Google Scholar
• Brush TP, Trinh S, Brawner CM, Ali KH, Hauke RJ, Elkahwaji JE. 2010. RBAC, a modified form of arabinoxylan from rice bran, impairs prostate cancer cell line proliferation, adhesion, and invasion in vitro [Abstract]. Cancer Res. 70(8_Supplement):5662–5662. doi: 10.1158/1538-7445.AM10-5662.
   Google Scholar
• Bukowski K, Kciuk M, Kontek R. 2020. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 21(9):3233. doi: 10.3390/ijms21093233.
   PubMed Web of Science ®Google Scholar
• Carvalho AS, Lagana D, Catford J, Shaw D, Bak N. 2020. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health. 25(1):22–29. doi: 10.1016/j.idh.2019.08.006.
   PubMed Web of Science ®Google Scholar
• Chatterjee A. 2013. Reduced glutathione: a radioprotector or a modulator of DNA-repair activity? Nutrients. 5(2):525–542. doi: 10.3390/nu5020525.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV. 2015. Myeloid dendritic cells: development, functions, and role in atherosclerotic inflammation. Immunobiology. 220(6):833–844. doi: 10.1016/j.imbio.2014.12.010.
   PubMed Web of Science ®Google Scholar
• Cholujova D, Jakubikova J, Czako B, Martisova M, Hunakova L, Duraj J, Mistrik M, Sedlak J. 2013. MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunol Immunother. 62(3):437–445. doi: 10.1007/s00262-012-1344-z.
   PubMed Web of Science ®Google Scholar
• Cholujova D, Jakubikova J, Sedlak J. 2009. BioBran-augmented maturation of human monocyte-derived dendritic cells. neo. 56(2):89–95. doi: 10.4149/neo_2009_02_89.
   Google Scholar
• Clark HR. 1999. The natural pharmacy. Winning the war against cancer: MGN-3: mushroom ammunition. Alternative Medicine Magazine. Eagan (MN): InnoVision Communications Health Media. p. 26–28.
   Google Scholar
• Dare AJ, Anderson BO, Sullivan R, Pramesh CS, Andre I, Adewole IF, Badwe RA, Gauvreau CL., et al. 2015. Surgical services for cancer care. In: Gelband H, Jha P, Sankaranarayanan R editors. Cancer: disease control priorities. 3rd ed. Washington (DC): the International Bank for Reconstruction and Development/the World Bank; p. 223–238.
   Google Scholar
• Deeks JJ, Higgins JP, Altman DG., et al. 2021. Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J editors. Cochrane handbook for systematic reviews of interventions version 62 (updated February 2021). London, UK: Cochrane Library.
   Google Scholar
• Delaney GP, Barton MB. 2015. Evidence-based estimates of the demand for radiotherapy. Clin Oncol. 27(2):70–76. doi: 10.1016/j.clon.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Deng Z, Wu S, Wang Y, Shi D. 2022. Circulating tumor cell isolation for cancer diagnosis and prognosis. eBioMedicine. 83:104237. doi: 10.1016/j.ebiom.2022.104237.
   PubMed Web of Science ®Google Scholar
• Du N, Guo F, Wang Y, Cui J. 2021. NK cell therapy: a rising star in cancer treatment. Cancers. 13(16):4129. doi: 10.3390/cancers13164129.
   PubMed Web of Science ®Google Scholar
• Elsaid AF, Agrawal S, Agrawal A, Ghoneum M. 2021. Dietary supplementation with Biobran/MGN-3 increases innate resistance and reduces the incidence of influenza-like illnesses in elderly subjects: a randomized, double-blind, placebo-controlled pilot clinical trial. Nutrients. 13(11):4133. doi: 10.3390/nu13114133.
   PubMed Web of Science ®Google Scholar
• Elsaid AF, Shaheen M, Ghoneum M. 2018. Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: a randomized, double-blind, placebo-controlled clinical trial. Exp Ther Med. 15(3):2313–2320. doi: 10.3892/etm.2018.5713.
   PubMed Web of Science ®Google Scholar
• Endo Y, Kanbayashi H. 2003. Modified rice bran beneficial for weight loss of mice as a major and acute adverse effect of cisplatin. Pharmacol Toxicol. 92(6):300–303. doi: 10.1034/j.1600-0773.2003.920608.x.
   PubMedGoogle Scholar
• Fan H, Walters CS, Dunston GM, Tackey R. 2002. IL-12 plays a significant role in the apoptosis of human T cells in the absence of antigenic stimulation. Cytokine. 19(3):126–137. doi: 10.1006/cyto.2002.1958.
   PubMed Web of Science ®Google Scholar
• Fox JT, Sakamuru S, Huang R, Teneva N, Simmons SO, Xia M, Tice RR, Austin CP, Myung K. 2012. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc Natl Acad Sci U S A. 109(14):5423–5428. doi: 10.1073/pnas.1114278109.
   PubMed Web of Science ®Google Scholar
• Fridrichova I, Kalinkova L, Ciernikova S. 2022. Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters? IJMS. 23(20):12141. doi: 10.3390/ijms232012141.
   Google Scholar
• Ghoneum M. 1998. Enhancement of human natural killer cell activity by modified arabinoxylane from rice bran (MGN-3). Int J Immunother. 14(2):89–99.
   Web of Science ®Google Scholar
• Ghoneum M. 1999. Immunostimulation and cancer prevention. Abstract presented at: 7th International Congress on Anti-Aging & Biomedical Technologies. Dec 11-13; Las Vegas (NV).
   Google Scholar
• Ghoneum M. 2016. From bench to bedside: the growing use of arabinoxylan rice bran (MGN-3/Biobran) in cancer immunotherapy. Austin Immunol. 1(2):1006.
   Google Scholar
• Ghoneum M., et al. 2023. Enhancing natural killer cell activity. In: Pak SC, Ooi SL, Micalos PS editors. Modified rice bran arabinoxylan: therapeutic applications in cancer and other diseases. Singapore: Springer Nature. p. 15–25.
   Google Scholar
• Ghoneum M, Abdulmalek S, Fadel HH. 2023. Biobran/MGN-3, an arabinoxylan rice bran, protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an in vitro and in silico study. Nutrients. 15(2):453. doi: 10.3390/nu15020453.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Abedi S. 2004. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharm Pharmacol. 56(12):1581–1588. doi: 10.1211/0022357044922.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Agrawal S. 2011. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran). Int J Immunopathol Pharmacol. 24(4):941–948. doi: 10.1177/039463201102400412.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Agrawal S. 2014. MGN-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of DEC-205 expression on dendritic cells. Int J Immunopathol Pharmacol. 27(4):523–530. doi: 10.1177/039463201402700408.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Badr El-Din NK, Abdel Fattah SM, Tolentino L. 2013. Arabinoxylan rice bran (MGN-3/Biobran) provides protection against whole-body γ-irradiation in mice via restoration of hematopoietic tissues. J Radiat Res. 54(3):419–429. doi: 10.1093/jrr/rrs119.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Badr El-Din NK, Ali DA, El-Dein MA. 2014. Modified arabinoxylan from rice bran, MGN-3/Biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro. Anticancer Res. 34(1):81–87.
   PubMedGoogle Scholar
• Ghoneum M, Brown J. 1999. NK Immunorestoration and cancer patients by MGN-3, a modified arabinoxylan rice bran (Study of 32 patients followed for up to 4 years). In: Klatz RM, Goldman R, editors. Anti-aging medical therapeutics. Marina del Rey (CA): Health Quest Publications; p. 217–226.
   Google Scholar
• Ghoneum M, El Sayed NS. 2021. Protective effect of Biobran/MGN-3 against sporadic Alzheimer’s disease mouse model: possible role of oxidative stress and apoptotic pathways. Oxid Med Cell Longev. 2021:8845064–8845015. doi: 10.1155/2021/8845064.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Gollapudi S. 2003. Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis. Cancer Lett. 201(1):41–49. doi: 10.1016/S0304-3835(03)00458-0.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Gollapudi S. 2004. Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae the baker’s yeast, in vitro. Anticancer Res. 24(3A):1455–1463.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Gollapudi S. 2005a. Modified arabinoxylan rice bran (MGN-3/Biobran) enhances yeast-induced apoptosis in human breast cancer cells in vitro. Anticancer Res. 25(2A):859–870.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Gollapudi S. 2005b. Synergistic role of arabinoxylan rice bran (MGN-3/Biobran) in S. cerevisiae-induced apoptosis of monolayer breast cancer MCF-7 cells. Anticancer Res. 25(6B):4187–4196.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Gollapudi S. 2011. Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro. Neoplasma. 58(2):118–123.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Jewett A. 2000. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect Prev. 24(4):314–324.
   PubMedGoogle Scholar
• Ghoneum M, Matsuura M, Gollapudp S. 2008. Modified arabinoxylan rice bran (MGN-3/Biobran) enhances intracellular killing of microbes by human phagocytic cells in vitro. Int J Immunopathol Pharmacol. 21(1):87–95. doi: 10.1177/039463200802100110.
   PubMed Web of Science ®Google Scholar
• Ghoneum M, Tachiki KH, Ueyama K, Makinodan T, Makhijani N, Yamaguchi D. 2000. Natural biological response modifier (MGN-3) shown to be ‑effective against tumor cell growth. Abstract presented at: 8th International Congress on Anti-Aging & Biomedical Technologies. Dec 14-17; Las Vegas (NV).
   Google Scholar
• Giese S, Sabell GR, Coussons-Read M. 2008. Impact of ingestion of rice bran and shitake mushroom extract on lymphocyte function and cytokine production in healthy rats. J Diet Suppl. 5(1):47–61. doi: 10.1080/19390210802329196.
   PubMedGoogle Scholar
• Gollapudi S, Ghoneum M. 2008. MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin. Cancer Detect Prev. 32(1):1–6. doi: 10.1016/j.cdp.2008.02.006.
   PubMedGoogle Scholar
• Golombick T, Diamond TH, Manoharan A, Ramakrishna R. 2016. Addition of rice bran arabinoxylan to curcumin therapy may be of benefit to patients with early-stage B-cell lymphoid malignancies (monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia): a preliminary clinical study. Integr Cancer Ther. 15(2):183–189. doi: 10.1177/1534735416635742.
   PubMed Web of Science ®Google Scholar
• Gonzalez H, Hagerling C, Werb Z. 2018. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 32(19–20):1267–1284. doi: 10.1101/gad.314617.118.
   PubMed Web of Science ®Google Scholar
• Götze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A. 2020. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer. 28(1):211–220. doi: 10.1007/s00520-019-04805-1.
   PubMed Web of Science ®Google Scholar
• Guan X. 2015. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 5(5):402–418. doi: 10.1016/j.apsb.2015.07.005.
   PubMed Web of Science ®Google Scholar
• Guichard N, Guillarme D, Bonnabry P, Fleury-Souverain S. 2017. Antineoplastic drugs and their analysis: a state of the art review. Analyst. 142(13):2273–2321. doi: 10.1039/c7an00367f.
   PubMed Web of Science ®Google Scholar
• Hajtó T. 2017. Can a standardized plant immunomodulator (rice bran arabinoxylan concentrate/MGN-3) increase the effects of MEK and BRAF inhibitors with clinical benefit? Case report of a patient with carcinoma in biliary duct. Res Rev Insights. 1(3):1–4.
   Google Scholar
• Hajtó T. 2018. New perspectives to improve the MHC-I unrestricted immune mechanisms against malignant tumors. Adv Clin Transl Res. 2(3):100014.
   Google Scholar
• Hajtó T. 2023. The therapeutic application of RBAC in cancer. In: Pak SC, Ooi SL, Micalos PS., editors. Modified rice bran arabinoxylan: therapeutic applications in cancer and other diseases. Singapore: Springer Nature. p. 67–78.
   Google Scholar
• Hajtó T, Adámy A, Langmár Z, Kirsch A, Ábrahám L, Perjési P, Németh P. 2013. Enhanced effectiveness of conventional oncotherapy with plant immunomodulators: overview of recent advances. Adv Med Plant Res. 1(3):56–65.
   Google Scholar
• Hajtó T, Baranyai L, Kirsch A, Kuzma M, Perjési P. 2015. Can a synergistic activation of pattern recognition receptors by plant immunomodulators enhance the effect of oncologic therapy? Case Report of a patient with uterus and ovary sarcoma. Clin Case Rep Rev. 1(10):235–238. doi: 10.15761/CCRR.1000176.
   Google Scholar
• Hajtó T, Horváth A, Baranyai L, Kuzma M, Perjési P. 2016a. Can the EGFR inhibitors increase the immunomodulatory effects of standardized plant extracts (mistletoe lectin and arabonoxylan) with clinical benefit? Case report of a patient with lung adenocarcinoma. Clin Case Rep Rev. 2(6):456–459. doi: 10.15761/CCRR.1000244.
   Google Scholar
• Hajtó T, Horváth A, Papp S. 2016b. Improvement of quality of life in tumor patients after an immunomodulatory treatment with standardized mistletoe lectin and arabinoxylan plant extracts. Int J Neurorehabil. 3(2):2–4.
   Google Scholar
• Hajtó T, Kirsch A. 2013. Case reports of cancer patients with hepatic metastases treated by standardized plant immunomodulatory preparations. J Can Res Updates. 2(1):1–9.
   Google Scholar
• Hajtó T, Péczely L, Kuzma M, Hormay E, Ollmann T, Jaksó P, Baranyai L, Karádi Z. 2022. Enhancing effect of streptozotocin-induced insulin deficit on antitumor innate immune defense in rats. Res Rev Insights. 6(1):1000170.
   Google Scholar
• Haque A, Brazeau D, Amin AR. 2021. Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds. Eur J Cancer. 149:165–183. doi: 10.1016/j.ejca.2021.03.009.
   PubMed Web of Science ®Google Scholar
• Hariton E, Locascio JJ. 2018. Randomised controlled trials – the gold standard for effectiveness research. BJOG. 125(13):1716–1716. doi: 10.1111/1471-0528.15199.
   PubMed Web of Science ®Google Scholar
• Hausman DM. 2019. What is cancer? Perspect Biol Med. 62(4):778–784. doi: 10.1353/pbm.2019.0046.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT, Tew KD. 2020. Oxidative stress in cancer. Cancer Cell. 38(2):167–197. doi: 10.1016/j.ccell.2020.06.001.
   PubMed Web of Science ®Google Scholar
• Hegyi G, Szasz O, Szasz A. 2013. Oncothermia: a new paradigm and promising method in cancer therapies. Acupunct Electrother Res. 38(3):161–197. doi: 10.3727/036012913X13831832269243.
   PubMed Web of Science ®Google Scholar
• Huang L, Jiang S, Shi Y. 2020. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020). J Hematol Oncol. 13(1):143. doi: 10.1186/s13045-020-00977-0.
   PubMed Web of Science ®Google Scholar
• Itoh Y, Mizuno M, Ikeda M, Nakahara R, Kubota S, Ito J, Okada T, Kawamura M, Kikkawa F, Naganawa S. 2015. A randomized, double-blind pilot trial of hydrolyzed rice bran versus placebo for radioprotective effect on acute gastroenteritis secondary to chemoradiotherapy in patients with cervical cancer. Evid Based Complement Alternat Med. 2015:974390–974396. doi: 10.1155/2015/974390.
   PubMed Web of Science ®Google Scholar
• Jacoby HI, Wnorowski G, Sakata K, Maeda H. 2001. The effect of MGN-3 on cisplatin and doxorubicin induced toxicity in the rat. J Nutraceuticals Funct Med Foods. 3(4):3–11. doi: 10.1300/J133v03n04_02.
   Google Scholar
• Ji MG, Lee YR, Nam YH, Castañeda R, Hong BN, Kang TH. 2020. Immunostimulatory action of high-content active arabinoxylan in rice bran. ACS Omega. 5(41):26374–26381. doi: 10.1021/acsomega.0c02472.
   PubMed Web of Science ®Google Scholar
• Kim DJ, Ryu S-N, Han SJ, Kim HY, Kim JH, Hong SG. 2011. In vivo immunological activity in fermentation with black rice bran. Korean J Food Nutr. 24:p. 273–281. Korean: The Korean Society of Food and Nutrition.
   Google Scholar
• Kim HY, Kim JH, Yang SB, Hong SG, Lee SA, Hwang SJ, Shin KS, Suh HJ, Park MH. 2007. A polysaccharide extracted from rice bran fermented with Lentinus edodes enhances natural killer cell activity and exhibits anticancer effects. J Med Food. 10(1):25–31. doi: 10.1089/jmf.2006.116.
   PubMed Web of Science ®Google Scholar
• Kim JM, Hong SG, Song BS, Sohn HJ, Baik H, Sung MK. 2020. Efficacy of cereal-based oral nutrition supplement on nutritional status, inflammatory cytokine secretion and quality of life in cancer patients under cancer therapy. J Cancer Prev. 25(1):55–63. doi: 10.15430/JCP.2020.25.1.55.
   PubMed Web of Science ®Google Scholar
• Kim K, Khang D. 2020. Past, present, and future of anticancer nanomedicine. Int J Nanomedicine. 15:5719–5743. doi: 10.2147/IJN.S254774.
   PubMed Web of Science ®Google Scholar
• Knudson AG. 2002. Cancer genetics. Am J Med Genet. 111(1):96–102. doi: 10.1002/ajmg.10320.
   PubMed Web of Science ®Google Scholar
• Koyama S, Nishikawa H. 2021. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer. 9(7):e002591. doi: 10.1136/jitc-2021-002591.
   PubMed Web of Science ®Google Scholar
• Lemoine M. 2022. Anya Plutynski’s explaining cancer: finding order in disorder. Philos Med. 3(1):1–8.
   Google Scholar
• Li C, Jiang P, Wei S, Xu X, Wang J. 2020. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 19(1):116. doi: 10.1186/s12943-020-01234-1.
   PubMed Web of Science ®Google Scholar
• Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y. 2021. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 6(1):404.
   PubMed Web of Science ®Google Scholar
• Lin W, Niu Z, Zhang H, Kong Y, Wang Z, Yang X, Yuan F. 2019. Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer. Int J Clin Exp Pathol. 12:3604–3612.
   PubMed Web of Science ®Google Scholar
• Lissoni P, Messina G, Brivio F, Fumagalli L, Rovelli F, Maruelli L, Miceli M, Marchiori P, Porro G, Held M. 2008. Modulation of the anticancer immunity by natural agents: inhibition of T regulatory lymphocyte generation by arabinoxylan in patients with locally limited or metastatic solid tumors. Cancer Ther. 6:1011–1016.
   Google Scholar
• Liu S, Edgerton SM, Moore DH, Ii, T, Ad. 2001. Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res. 7:1716–1723.
   PubMed Web of Science ®Google Scholar
• Loef M, Walach H. 2020. Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis. BMC Complement Med Ther. 20(1):227. doi: 10.1186/s12906-020-03013-3.
   PubMedGoogle Scholar
• Lugini L, Lozupone F, Matarrese P, Funaro C, Luciani F, Malorni W, Rivoltini L, Castelli C, Tinari A, Piris A, et al. 2003. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest. 83(11):1555–1567. doi: 10.1097/01.lab.0000098425.03006.42.
   PubMed Web of Science ®Google Scholar
• Majeed H, Gupta V. 2023. Adverse effects of radiation therapy. Treasure Island (FL): StatPearls Publishing; [accessed 2023 Nov 13]. https://www.ncbi.nlm.nih.gov/books/NBK563259/.
   Google Scholar
• Majeed M, Hakeem KR, Rehman RU. 2021. Mistletoe lectins: from interconnecting proteins to potential tumour inhibiting agents. Phytomed Plus. 1(3):100039. doi: 10.1016/j.phyplu.2021.100039.
   Google Scholar
• Martins-Teixeira MB, Carvalho I. 2020. Antitumour anthracyclines: progress and perspectives. ChemMedChem. 15(11):933–948. doi: 10.1002/cmdc.202000131.
   PubMed Web of Science ®Google Scholar
• Masood AI, Sheikh R, Anwer RA. 2013. BIOBRAN MGN-3"; Effect of reducing side effects of chemotherapy in breast cancer patients. Prof Med J. 20(1):13–16.
   Google Scholar
• Mazzotti E, Antonini Cappellini GC, Buconovo S, Morese R, Scoppola A, Sebastiani C, Marchetti P. 2012. Treatment-related side effects and quality of life in cancer patients. Support Care Cancer. 20(10):2553–2557. doi: 10.1007/s00520-011-1354-y.
   PubMed Web of Science ®Google Scholar
• Melaiu O, Lucarini V, Cifaldi L, Fruci D. 2019. Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol. 10:3038. doi: 10.3389/fimmu.2019.03038.
   PubMed Web of Science ®Google Scholar
• Miura T, Chiba M, Miyazaki Y, Kato Y, Maeda H. 2013. Chemical structure of the component involved in immunoregulation. BioBran/MGN-3 (Rice Bran Arabinoxylan Coumpound): basic and clinical application to integrative medicine. 2nd ed. Tokyo (Japan): BioBran Research Foundation; p. 14–22.
   Google Scholar
• Morse W, Nawaz H, Choudhry AA. 2023. Combination of chemotherapeutic agents and biological response modifiers (immunotherapy) in triple-negative/Her2( +) breast cancer, multiple myeloma, and non-small-cell lung cancer. J Egypt Natl Canc Inst. 34(1):58. doi: 10.1186/s43046-022-00159-8.
   PubMed Web of Science ®Google Scholar
• Muhammad N, Usmani D, Tarique M, Naz H, Ashraf M, Raliya R, Tabrez S, Zughaibi TA, Alsaieedi A, Hakeem IJ, et al. 2022. The role of natural products and their multitargeted approach to treat solid cancer. Cells. 11(14):2209. doi: 10.3390/cells11142209.
   PubMed Web of Science ®Google Scholar
• Nasa P, Jain R, Juneja D. 2021. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol. 11(4):116–129. doi: 10.5662/wjm.v11.i4.116.
   PubMedGoogle Scholar
• National Cancer Institute. 2023. Cancer. [accessed 2023 Oct 20]. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cancer.
   Google Scholar
• National Heart Lung and Blood Institute. 2013. Study quality assessment tools. [accessed 2023 Oct 20]. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
   Google Scholar
• Nesher L, Rolston KVI. 2014. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 42(1):5–13. doi: 10.1007/s15010-013-0525-9.
   PubMed Web of Science ®Google Scholar
• Noaman E, Badr El-Din NK, Bibars MA, Abou Mossallam AA, Ghoneum M. 2008. Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma. Cancer Lett. 268(2):348–359. doi: 10.1016/j.canlet.2008.04.012.
   PubMed Web of Science ®Google Scholar
• Nordvig J, Aagaard T, Daugaard G, Brown P, Sengeløv H, Lundgren J, Helleberg M. 2018. Febrile neutropenia and long-term risk of infection among patients treated with chemotherapy for malignant diseases. Open Forum Infect Dis. 5(10):ofy255.
   PubMed Web of Science ®Google Scholar
• Ohue Y, Nishikawa H. 2019. Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target? Cancer Sci. 110(7):2080–2089. doi: 10.1111/cas.14069.
   PubMed Web of Science ®Google Scholar
• Ooi SL, McMullen D, Golombick T, Nut D, Pak SC. 2018. Evidence-based review of BioBran/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment. Integr Cancer Ther. 17(2):165–178. doi: 10.1177/1534735417735379.
   PubMed Web of Science ®Google Scholar
• Ooi SL, Micalos PS, Kim J, Pak SC. 2023a. Rice bran arabinoxylan compound as a natural product for cancer treatment – an evidence-based assessment of the effects and mechanisms. Preprints. 2023: 2023101057. doi: 10.20944/preprints202310.1057.v1.
   Google Scholar
• Ooi SL, Micalos PS, Pak SC. 2023b. Modified rice bran arabinoxylan as a nutraceutical in health and disease – a scoping review with bibliometric analysis. PLOS One. 18(8):e0290314. doi: 10.1371/journal.pone.0290314.
   PubMedGoogle Scholar
• Ooi SL, Micalos PS, Pak SC. 2023c. Modified rice bran arabinoxylan by Lentinus edodes mycelial enzyme as an immunoceutical for health and aging – a comprehensive literature review. Molecules. 28(17):6313. doi: 10.3390/molecules28176313.
   PubMed Web of Science ®Google Scholar
• Ooi SL, Pak SC, Micalos PS, Schupfer E, Lockley C, Park MH, Hwang SJ. 2021. The health-promoting properties and clinical applications of rice bran arabinoxylan modified with shiitake mushroom enzyme – a narrative review. Molecules. 26(9):2539. doi: 10.3390/molecules26092539.
   PubMed Web of Science ®Google Scholar
• Palmer AC, Sorger PK. 2017. Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy. Cell. 171(7):1678–1691.e13. doi: 10.1016/j.cell.2017.11.009.
   PubMed Web of Science ®Google Scholar
• Pasiarski M, Grywalska E, Kosmaczewska A, Góźdź S, Roliński J. 2013. The frequency of myeloid and lymphoid dendritic cells in multiple myeloma patients is inversely correlated with disease progression. Postepy Hig Med Dosw (Online). 67:926–932. doi: 10.5604/17322693.1065871.
   PubMedGoogle Scholar
• Pérez-Martínez A, Valentín J, Fernández L, Hernández-Jiménez E, López-Collazo E, Zerbes P, Schwörer E, Nuñéz F, Martín IG, Sallis H, et al. 2015. Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo. Cytotherapy. 17(5):601–612. doi: 10.1016/j.jcyt.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Pescatore FM, Přestáno C, Kichikova M. 2022. RBAC and its role with the immune system. Altern Ther Health Med. 28(1):8–10.
   PubMed Web of Science ®Google Scholar
• Petrovics G, Szigeti G, Hamvas S, Máté Á, Betlehem J, Hegyi G. 2016. Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3Arabinoxylane) and targeted radiofrequency heat therapy. Eur J Integr Med. 8:29–35. doi: 10.1016/j.eujim.2016.10.004.
   Web of Science ®Google Scholar
• Pfeffer CM, Singh ATK. 2018. Apoptosis: a target for anticancer therapy. IJMS. 19(2):448. doi: 10.3390/ijms19020448.
   Google Scholar
• Phillips DH, Arlt VM. 2009. Genotoxicity: damage to DNA and its consequences. In: Luch A, editor. Molecular, clinical and environmental toxicology. Basel (Switzerland): Birkhäuser Basel; p. 87–110.
   Google Scholar
• Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D’Orazi G. 2016. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 8(4):603–619. doi: 10.18632/aging.100934.
   PubMedGoogle Scholar
• Raskov H, Orhan A, Christensen JP, Gögenur I. 2021. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 124(2):359–367. doi: 10.1038/s41416-020-01048-4.
   PubMed Web of Science ®Google Scholar
• Redza-Dutordoir M, Averill-Bates DA. 2016. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta Mol Cell Res. 1863(12):2977–2992. doi: 10.1016/j.bbamcr.2016.09.012.
   PubMed Web of Science ®Google Scholar
• Riggan L, Shah S, O’Sullivan TE. 2021. Arrested development: suppression of NK cell function in the tumor microenvironment. Clin Transl Immunology. 10(1):e1238.
   PubMed Web of Science ®Google Scholar
• Robb KA, Simon AE, Miles A, Wardle J. 2014. Public perceptions of cancer: a qualitative study of the balance of positive and negative beliefs. BMJ Open. 4(7):e005434–e005434. doi: 10.1136/bmjopen-2014-005434.
   PubMed Web of Science ®Google Scholar
• Rosenberg J, Huang J. 2018. CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy. Curr Opin Chem Eng. 19:9–20. doi: 10.1016/j.coche.2017.11.006.
   PubMed Web of Science ®Google Scholar
• Salako O, Okunade KS, Adeniji AA, Fagbenro GT, Afolaranmi OJ. 2021. Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria. ecancer. 15:1188. doi: 10.3332/ecancer.2021.1188.
   PubMed Web of Science ®Google Scholar
• Schegoleva AA, Khozyainova AA, Gerashchenko TS, Zhuikova LD, Denisov EV. 2022. Metastasis prevention: targeting causes and roots. Clin Exp Metastasis. 39(4):505–519. doi: 10.1007/s10585-022-10162-x.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Lügering N, Pauels H-G, Schulze-Osthoff K, Domschke W, Kucharzik T. 2000. IL-10 induces apoptosis in human monocytes involving the CD95 receptor/ligand pathway. Eur J Immunol. 30(6):1769–1777. doi: 10.1002/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9.
   PubMed Web of Science ®Google Scholar
• Shalapour S, Karin M. 2015. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest. 125(9):3347–3355. doi: 10.1172/JCI80007.
   PubMed Web of Science ®Google Scholar
• Shamekhi S, Abdolalizadeh J, Ostadrahimi A, Mohammadi SA, Barzegari A, Lotfi H, Bonabi E, Zarghami N. 2020. Apoptotic effect of Saccharomyces cerevisiae on human colon cancer sw480 cells by regulation of Akt/NF-ĸB signaling pathway. Probiotics & Antimicro Prot. 12(1):311–319. doi: 10.1007/s12602-019-09528-7.
   PubMed Web of Science ®Google Scholar
• Shankar MG, Swetha M, Keerthana CK, Rayginia TP, Anto RJ. 2022. Cancer chemoprevention: a strategic approach using phytochemicals. Front Pharmacol. 12:809308.
   PubMed Web of Science ®Google Scholar
• SjØgren K, Jacobsen KA, GrØnberg BH, Halvorsen TO. 2020. Timing of severe toxicity from chemotherapy in patients with lung cancer. Anticancer Res. 40(11):6399–6406. doi: 10.21873/anticanres.14661.
   PubMed Web of Science ®Google Scholar
• Sojka DK, Huang Y-H, Fowell DJ. 2008. Mechanisms of regulatory T-cell suppression – a diverse arsenal for a moving target. Immunology. 124(1):13–22. doi: 10.1111/j.1365-2567.2008.02813.x.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Takahara K, Sano K. 2004. The life prolongation and QOL improvement effect of rice bran arabinoxylan derivative (MGN-3, Biobran) for progressive cancer. Clin Pharmacol Ther . 14:267–271.
   Google Scholar
• Tan DFS, Flores JAS. 2020. The immunomodulating effects of arabinoxylan rice bran (Lentin) on hematologic profile, nutritional status and quality of life among head and neck carcinoma patients undergoing radiation therapy: a double blind randomized control trial. Radiol J. 12:11–16.
   Google Scholar
• Tazawa K, Namikawa H, Oida N, Itoh K, Yatsuzuka M, Koike J, Masada M, Maeda H. 2000. Scavenging activity of MGN-3 (arabinoxylane from rice bran) with natural killer cell activity on free radicals. Biotherapy. 14:493–495.
   Google Scholar
• Togashi Y, Shitara K, Nishikawa H. 2019. Regulatory T cells in cancer immunosuppression—implications for anticancer therapy. Nat Rev Clin Oncol. 16(6):356–371. doi: 10.1038/s41571-019-0175-7.
   PubMed Web of Science ®Google Scholar
• Tsao AS, Kim ES, Hong WK. 2004. Chemoprevention of cancer. CA Cancer J Clin. 54(3):150–180. doi: 10.3322/canjclin.54.3.150.
   PubMed Web of Science ®Google Scholar
• Wang LH, Wu CF, Rajasekaran N, Shin YK. 2018. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem. 51(6):2647–2693. doi: 10.1159/000495956.
   PubMedGoogle Scholar
• Weston A, Harris CC. 2003. Multistage carcinogenesis. In Kufe DW, Pollock RE, Weichselbaum RR., editors. Holland-Frei cancer medicine. 6th ed. Hamilton (ON):B.C. Decker.
   Google Scholar
• Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. 2019. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 20(6):769–780. doi: 10.1016/S1470-2045(19)30163-9.
   PubMed Web of Science ®Google Scholar
• Wu Z, Li S, Zhu X. 2021. The mechanism of stimulating and mobilizing the immune system enhancing the anti-tumor immunity. Front Immunol. 12:682435. doi: 10.3389/fimmu.2021.682435.
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang F, Li H, Yang L, Lv T, Gu W, Song Y. 2017. Circulating tumor cells were associated with the number of T lymphocyte subsets and NK cells in peripheral blood in advanced non-small-cell lung cancer. Dis Markers. 2017:1–6. doi: 10.1155/2017/5727815.
   Web of Science ®Google Scholar
• Ye Y, Gaugler B, Mohty M, Malard F. 2020. Plasmacytoid dendritic cell biology and its role in immune-mediated diseases. Clin Transl Immunology. 9(5):e1139.
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhang J, Wang J, Sun B. 2019. The anti-cancer activity and potential clinical application of rice bran extracts and fermentation products. RSC Adv. 9(31):18060–18069. doi: 10.1039/C9RA02439E.
   PubMed Web of Science ®Google Scholar
• Zabor EC, Kaizer AM, Hobbs BP. 2020. Randomized controlled trials. Chest. 158(1):S79–S87. doi: 10.1016/j.chest.2020.03.013.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu J, Ge S, Chen C, Li S, Wu X, Feng X, Wang Y, Cai D. 2019. Saikosaponin A inhibits breast cancer by regulating Th1/Th2 balance. Front Pharmacol. 10:624. doi: 10.3389/fphar.2019.00624.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Cheng W, Qu W, Wang K. 2020. Arabinoxylan rice bran (MGN-3/Biobran) alleviates radiation-induced intestinal barrier dysfunction of mice in a mitochondrion-dependent manner. Biomed Pharmacother. 124:109855. doi: 10.1016/j.biopha.2020.109855.
   PubMed Web of Science ®Google Scholar
• Zhou B, Lawrence T, Liang Y. 2021. The role of plasmacytoid dendritic cells in cancers. Front Immunol. 12:749190. doi: 10.3389/fimmu.2021.749190.
   PubMedGoogle Scholar